| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/18/1998 | CN1176598A Method and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 03/17/1998 | US5728846 Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives |
| 03/17/1998 | US5728716 Trachykinin peptide for nervous system disorders and cardiovascular disorders |
| 03/17/1998 | US5728704 Substituted pyridmidines for control of diabetic complications |
| 03/17/1998 | US5728689 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
| 03/17/1998 | CA1339724C Anti-inflammatory factor, method of isolation, and use |
| 03/12/1998 | WO1998009985A2 Anti-inflammatory peptides and uses thereof |
| 03/12/1998 | WO1998009984A1 Central nervous system-derived immune privilege factor and uses thereof |
| 03/12/1998 | WO1998009977A1 Tetrahydronapthalene derivatives and their therapeutic use |
| 03/12/1998 | WO1998009969A1 Novel aryl-pyridazines |
| 03/12/1998 | WO1998009961A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 03/12/1998 | WO1998009957A1 Compounds for and a method of inhibiting matrix metalloproteinases |
| 03/12/1998 | WO1998009940A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 03/12/1998 | WO1998009938A1 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity |
| 03/12/1998 | WO1998009934A1 Matrix metalloproteinase inhibitors and their therapeutic uses |
| 03/12/1998 | WO1998009654A1 Pharmaceutical composition containing lornoxicam and a disodic salt of edta |
| 03/12/1998 | WO1998009626A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 03/12/1998 | WO1997049827A3 Adenoviral mediated gene transfer in adipocytes and related implants |
| 03/12/1998 | CA2264959A1 Central nervous system-derived immune privilege factor and uses thereof |
| 03/12/1998 | CA2264798A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 03/12/1998 | CA2264737A1 Tetrahydronaphthalene derivatives and their therapeutic use |
| 03/12/1998 | CA2264285A1 Anti-inflammatory peptides and uses thereof |
| 03/12/1998 | CA2263686A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 03/12/1998 | CA2263586A1 Novel aryl-pyridazines |
| 03/12/1998 | CA2263250A1 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity |
| 03/12/1998 | CA2256716A1 Matrix metalloproteinase inhibitors and their therapeutic uses |
| 03/12/1998 | CA2256631A1 Compounds for and a method of inhibiting matrix metalloproteinases |
| 03/11/1998 | EP0827403A1 Use of calcium intracellular store inactivators and formulations thereof as cell growth inhibitors |
| 03/11/1998 | EP0786997A4 Muscarine antagonists |
| 03/11/1998 | EP0660717B1 Aminosteroids for ophthalmic use |
| 03/11/1998 | EP0636125B1 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 03/11/1998 | CN1175431A Powder medicine for otitis |
| 03/05/1998 | WO1998008864A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE |
| 03/05/1998 | WO1998008853A1 Phosphinic acid amides as matrix metalloprotease inhibitors |
| 03/05/1998 | WO1998008850A1 Spirocyclic metalloprotease inhibitors |
| 03/05/1998 | WO1998008840A1 Integrin antagonists |
| 03/05/1998 | WO1998008834A1 Benzylamine derivatives, their preparation and their application in therapeutics |
| 03/05/1998 | WO1998008827A1 Heterocyclic metalloprotease inhibitors |
| 03/05/1998 | WO1998008826A1 Piperazino derivatives as neurokinin antagonists |
| 03/05/1998 | WO1998008825A1 1,4-heterocyclic metalloprotease inhibitors |
| 03/05/1998 | WO1998008823A1 Heterocyclic metalloprotease inhibitors |
| 03/05/1998 | WO1998008822A1 1,3-diheterocyclic metalloprotease inhibitors |
| 03/05/1998 | WO1998008815A1 Substituted cyclic amine metalloprotease inhibitors |
| 03/05/1998 | WO1998008814A1 Bidentate metalloprotease inhibitors |
| 03/05/1998 | WO1998008533A1 Sustained peptide-release formulation |
| 03/05/1998 | WO1998008529A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 03/05/1998 | WO1998008528A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 03/05/1998 | WO1998008518A1 Compositions and methods for administering integrin receptor antagonists |
| 03/05/1998 | WO1998008503A1 Therapeutic methods and compositions involving isoflavones |
| 03/05/1998 | WO1997037688A3 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity |
| 03/05/1998 | CA2265049A1 Therapeutic methods and compositions involving isoflavones |
| 03/05/1998 | CA2264309A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 03/05/1998 | CA2264266A1 1,3-diheterocyclic metalloprotease inhibitors |
| 03/05/1998 | CA2264045A1 Heterocyclic metalloprotease inhibitors |
| 03/05/1998 | CA2264044A1 Spirocyclic metalloprotease inhibitors |
| 03/05/1998 | CA2263999A1 Integrin antagonists |
| 03/05/1998 | CA2263998A1 Compositions and methods for administering integrin receptor antagonists |
| 03/05/1998 | CA2263932A1 1,4-heterocyclic metalloprotease inhibitors |
| 03/05/1998 | CA2263928A1 Substituted cyclic amine metalloprotease inhibitors |
| 03/05/1998 | CA2263917A1 Heterocyclic metalloprotease inhibitors |
| 03/05/1998 | CA2263914A1 Bidentate metalloprotease inhibitors |
| 03/05/1998 | CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use |
| 03/04/1998 | EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase |
| 03/04/1998 | EP0826373A1 Preventive for postoperative astigmatism |
| 03/04/1998 | EP0826368A1 Use of retinoids for the preparation of a medicament for treating disorders related to VEGF overexpression |
| 03/04/1998 | EP0826000A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses |
| 03/04/1998 | EP0825996A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
| 03/04/1998 | EP0825993A1 Xanthines and their therapeutic use |
| 03/04/1998 | EP0825980A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylakenyl derivatives as therapeutic agents for the treatment of ocular hypertension |
| 03/04/1998 | EP0825863A1 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
| 03/04/1998 | CN1174836A Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 03/04/1998 | CN1174718A Traditional Chinese medicine for indication nearsight |
| 03/03/1998 | US5723499 Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 03/02/1998 | CA2213690A1 Use of retinoid in preparing a medication to treat disorders related to overexpression of vegf |
| 02/26/1998 | WO1998007435A1 Eye treatments using synthetic thyroid hormone compositions |
| 02/25/1998 | EP0824917A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis |
| 02/25/1998 | EP0824916A1 Pranoprofen eyedrops containing organic amine |
| 02/25/1998 | EP0824910A2 Use of a Krill Enzyme for the Treatment of Dental Plaque |
| 02/25/1998 | EP0824544A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use |
| 02/25/1998 | EP0824543A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use |
| 02/25/1998 | EP0824538A1 Saccharopeptides and derivatives thereof |
| 02/25/1998 | EP0824530A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 02/25/1998 | CN1174049A Drop for otitis media |
| 02/24/1998 | US5721206 Stimulating the eye cell growth with interferons; preventing eye disease and degradation |
| 02/19/1998 | WO1998006734A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/19/1998 | WO1998006406A1 Mannose-6-phosphate composition and its use in treating fibrotic disorders |
| 02/19/1998 | WO1998006402A1 Treatment of the common cold or allergic rhinitis |
| 02/19/1998 | WO1998006394A1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists |
| 02/19/1998 | WO1998006379A1 Pharmaceutical compositions |
| 02/19/1998 | WO1998001124A3 Pharmaceutical preparation containing nimesulide for topical use |
| 02/19/1998 | CA2263550A1 Treatment of the common cold or allergic rhinitis |
| 02/19/1998 | CA2263163A1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists |
| 02/18/1998 | EP0823906A1 Piperazino derivatives as neurokinin antagonists |
| 02/18/1998 | EP0823903A1 Heterocyclic diaryl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof |
| 02/18/1998 | EP0823895A1 Fatty acid esters as bioactive compounds |
| 02/18/1998 | EP0823889A1 1,3-propane diol derivatives as bioactive compounds |
| 02/17/1998 | US5718899 High concentration of immunoglobulins |
| 02/12/1998 | WO1998005781A1 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | WO1998005779A1 Modified tie-2-receptor ligands |
| 02/12/1998 | WO1998005660A1 Pyrrolo(3,2-c) quinoline derivatives |